SCHEMBL27786170

SCHEMBL27786170

C#Cc1cn(C2OC(CO)CC2C#C)c2ncnc(N)c12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 12/20 0.63
▸ DOT1L Q8TEK3 2/20 0.63
▸ DAPK3 O43293 1/20 0.53
▸ MAP4K4 O95819 1/20 0.53
▸ PAK4 O96013 1/20 0.53
▸ ABL1 P00519 1/20 0.53
▸ LCK P06239 1/20 0.53
▸ FYN P06241 1/20 0.53
▸ CSF1R P07333 1/20 0.53
▸ RET P07949 1/20 0.53
▸ IGF1R P08069 1/20 0.53
▸ FGFR1 P11362 1/20 0.53
▸ PRKACA P17612 1/20 0.53
▸ FLT1 P17948 1/20 0.53
▸ LTK P29376 1/20 0.53
▸ KDR P35968 1/20 0.53
▸ MAP2K2 P36507 1/20 0.53
▸ FLT3 P36888 1/20 0.53
▸ MAPK8 P45983 1/20 0.53
▸ CSNK1A1 P48729 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20938191 0.88 ADK (0.67) ADKDOT1LDAPK3MAP4K4PAK4
SCHEMBL12154911 0.88 ADK (0.48) ADKDOT1LPRMT5WDR77NPC1
SCHEMBL27764443 0.88 ADK (0.53) ADKDOT1LPRMT5WDR77HASPIN
SCHEMBL27786173 0.88 ADK (0.48) ADKDOT1LPRMT5WDR77NPC1
SCHEMBL14134780 0.88 ADK (0.53) ADKDOT1LPRMT5WDR77HASPIN
SCHEMBL18672066 0.80 AHCY (0.57) DOT1L
SCHEMBL27764503 0.79 ADK (0.51) ADKPRMT5WDR77METTL3
SCHEMBL1738494 0.78 ADK (0.61) ADKDOT1LFLT3CDK5PRMT5
SCHEMBL6732487 0.78 ADK (0.61) ADKDOT1LFLT3CDK5PRMT5
SCHEMBL16978197 0.78 ADK (1.00) ADKDOT1LPRMT5WDR77TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101600726-A The novel nucleoside analogs that is used for the treatment of virus infection NOVARTIS AG (CH) 2009-12-09 — — CN disclosed
Send feedback